Corcept Phase 2 study of ALS drug fails to meet primary endpoint
| TGFRX Fund | USD 45.83 0.41 0.89% |
Slightly above 61% of Tanaka Growth's investor base is looking to short. The analysis of overall sentiment of trading Tanaka Growth Fund mutual fund suggests that many investors are alarmed at this time. Tanaka Growth's investing sentiment can be driven by a variety of factors including economic data, Tanaka Growth's earnings reports, geopolitical events, and overall market trends.
Tanaka |
Corcept said a Phase 2 study evaluating its drug candidate dazucorilant in patients with ALS failed to meet its primary endpoint, but a long-term study will continue.
Read at seekingalpha.com
 |
Tanaka Growth Fundamental Analysis
We analyze Tanaka Growth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanaka Growth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanaka Growth based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Tanaka Growth is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Tanaka Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tanaka Growth mutual fund to make a market-neutral strategy. Peer analysis of Tanaka Growth could also be used in its relative valuation, which is a method of valuing Tanaka Growth by comparing valuation metrics with similar companies.
Peers
Tanaka Growth Related Equities
| RCMFX | Schwartz Value | 0.15 | ||||
| OBMCX | Oberweis Micro | 0.09 | ||||
| TFFYX | Touchstone Focused | 0.28 | ||||
| JMCGX | Jacob Micro | 0.58 | ||||
| JSCGX | Jacob Small | 0.96 |
Other Information on Investing in Tanaka Mutual Fund
Tanaka Growth financial ratios help investors to determine whether Tanaka Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tanaka with respect to the benefits of owning Tanaka Growth security.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |